![Nicholas Maestas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Maestas
Financieel Directeur/CFO bij
RANI THERAPEUTICS HOLDINGS, INC.
Vermogen: 903 $ op 31-05-2026
Profiel
Nicholas Maestas is currently Chief Financial & Accounting Officer at Rani Therapeutics Holdings, Inc. since 2026.
Formerly, Mr. Maestas was Chief Financial Officer, Secretary & Head-Strategy at Tempest Therapeutics, Inc. from 2025 to 2026, Head-Financial Planning & Analysis at Alector, Inc. from 2019 to 2021, and Senior Director-Corporate Development & Operations at Immune Design Corp.
in 2019.
Mr. Maestas completed undergraduate education at the University of California, Berkeley.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 590 ( 0% ) | 903 $ | 31-05-2026 |
Actieve functies van Nicholas Maestas
| Bedrijven | Functie | Begin |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Financieel Directeur/CFO | 29-06-2026 |
Eerdere bekende functies van Nicholas Maestas
| Bedrijven | Functie | Einde |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Financieel Directeur/CFO | 05-06-2026 |
| ALECTOR, INC. | Corporate Officer/Principal | 01-07-2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 01-07-2019 |
Opleiding van Nicholas Maestas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Kies MarketScreener 
